Acute Coronary Syndrome - Nursing Case Study
Pathophysiology
• Primary mechanism: Plaque rupture in the coronary arteries leads to the exposure of underlying collagen and tissue factors, triggering platelet activation and aggregation, forming a thrombus that occludes the artery, reducing blood flow to the heart muscle.
• Secondary mechanism: Endothelial dysfunction contributes to the instability of atherosclerotic plaques by impairing the protective vascular lining, promoting inflammation and further enhancing thrombus formation.
• Key complication: Reduced myocardial perfusion due to arterial blockage leads to ischemia, resulting in chest pain (angina) and, if prolonged, myocardial necrosis (heart tissue death), which can progress to myocardial infarction.
Patient Profile
Demographics:
65-year-old male, retired construction worker
History:
• Key past medical history: Hypertension, Type 2 Diabetes Mellitus, Hyperlipidemia
• Current medications: Metformin, Lisinopril, Atorvastatin, Aspirin
• Allergies: Penicillin
Current Presentation:
• Chief complaint: Chest pain
• Key symptoms: Severe chest discomfort radiating to the left arm, shortness of breath, nausea, diaphoresis
• Vital signs: Blood pressure 95/60 mmHg, heart rate 110 bpm, respiratory rate 24 breaths per minute, oxygen saturation 90% on room air, temperature 98.6°F
Section 1
As the healthcare team initiates treatment for the suspected acute coronary syndrome, further initial assessment findings reveal additional concerning details. Upon physical examination, the patient exhibits cool, clammy skin and peripheral cyanosis, indicating compromised perfusion. Auscultation of the lungs reveals bilateral crackles, suggesting pulmonary congestion, likely secondary to left ventricular dysfunction. The patient's jugular venous pressure is elevated, pointing toward potential heart failure. Despite the administration of supplemental oxygen, the patient's oxygen saturation remains suboptimal at 92%.
Electrocardiogram (ECG) results show ST-segment elevation in the inferior leads, confirming an acute ST-elevation myocardial infarction (STEMI). Blood tests indicate elevated cardiac biomarkers, including troponin I, which further supports myocardial injury. The patient’s blood glucose level is elevated at 220 mg/dL, complicating the metabolic response. Renal function tests reveal a slight increase in creatinine levels, suggesting the onset of acute kidney injury possibly due to decreased renal perfusion.
The healthcare team promptly initiates dual antiplatelet therapy, along with intravenous nitroglycerin to alleviate chest pain and improve coronary blood flow. However, the patient's blood pressure remains low despite fluid resuscitation, raising concerns about cardiogenic shock. The development of pulmonary edema necessitates the cautious use of diuretics to manage fluid overload, while balancing the risk of further hypotension. These findings underscore the need for urgent coronary intervention to restore myocardial perfusion and prevent further complications, such as arrhythmias or worsening heart failure, marking a critical juncture in the patient's treatment journey.
Section 2
As the healthcare team continues to address the patient's acute coronary syndrome, they closely monitor the patient's response to the initiated interventions. Despite the administration of intravenous nitroglycerin and dual antiplatelet therapy, the patient begins to exhibit signs of increasing respiratory distress. The respiratory rate has escalated to 28 breaths per minute, and the patient is visibly using accessory muscles to breathe. Auscultation reveals worsening bilateral crackles, indicative of escalating pulmonary edema. The oxygen saturation has further decreased to 88%, despite supplemental oxygen via a non-rebreather mask, necessitating a reassessment of the current treatment strategy.
In light of these developments, a chest X-ray is performed, revealing diffuse alveolar infiltrates consistent with pulmonary edema, confirming the severity of left-sided heart failure. The patient's blood pressure remains precariously low at 85/55 mmHg, despite cautious fluid administration and diuretic therapy, indicating the persistence of cardiogenic shock. An echocardiogram is conducted urgently, revealing a significantly reduced ejection fraction of 30%, consistent with severe left ventricular systolic dysfunction. These findings suggest that the current heart failure and shock management strategies are insufficient, prompting consideration of advanced hemodynamic support.
In response to the deteriorating condition, the healthcare team explores the possibility of initiating inotropic support to enhance cardiac output and improve perfusion. The patient is started on a low-dose infusion of dobutamine, with careful titration to avoid exacerbating myocardial oxygen demand. The multidisciplinary team also prepares for an emergent percutaneous coronary intervention (PCI) to restore coronary blood flow and prevent further myocardial damage. This critical intervention aims to stabilize the patient's hemodynamics and mitigate the risk of arrhythmias or further complications, underscoring the urgent need for comprehensive cardiovascular support.
Section 3
As the healthcare team closely monitors the patient's response to the initiated dobutamine infusion, there is cautious optimism regarding the improvement of cardiac output. Within the first hour of treatment, the patient's hemodynamic parameters are reassessed. The heart rate has increased to 105 beats per minute, and although the mean arterial pressure (MAP) rises slightly to 65 mmHg, there remains a delicate balance between optimizing perfusion and avoiding tachycardia-induced ischemia. The patient's respiratory status, however, continues to be a major concern. The respiratory rate remains elevated at 26 breaths per minute, and the oxygen saturation, although slightly improved to 90%, still necessitates close observation.
The team receives laboratory results from arterial blood gas analysis, which reveal a pH of 7.32, PaCO2 of 50 mmHg, and PaO2 of 58 mmHg. These findings indicate a mixed respiratory and metabolic acidosis, likely a consequence of ongoing hypoxemia and impaired tissue perfusion. The laboratory values underscore the need for continued advanced respiratory support, and an urgent discussion is held regarding the potential initiation of non-invasive positive pressure ventilation (NIPPV) to alleviate the work of breathing and improve gas exchange.
In parallel, the patient's renal function is becoming a concern, as evidenced by a rising serum creatinine level of 2.1 mg/dL and a decreasing urine output of less than 20 mL/hr. This suggests the development of acute kidney injury secondary to poor perfusion, necessitating further careful adjustment of diuretic therapy and fluid management. The interdisciplinary team remains vigilant, recalibrating the treatment plan to address the evolving complications while preparing for the imminent percutaneous coronary intervention. The integration of these clinical findings into the patient's care plan exemplifies the need for continuous reassessment and dynamic problem-solving in the face of complex clinical scenarios.
Section 4
As the team initiates non-invasive positive pressure ventilation (NIPPV) to address the patient's respiratory compromise, there is an immediate focus on reassessing the patient's hemodynamic and respiratory status. The NIPPV seems to be well tolerated, and within the first 30 minutes, a repeat arterial blood gas analysis shows modest improvement: pH has risen to 7.35, PaCO2 has decreased to 45 mmHg, and PaO2 has increased to 64 mmHg. These changes suggest a partial correction of the respiratory acidosis and an improvement in oxygenation. The team notes a slight decrease in respiratory rate to 22 breaths per minute, indicating reduced respiratory distress. Despite these positive changes, the patient's heart rate remains elevated at 102 beats per minute, and MAP hovers around 67 mmHg, necessitating ongoing scrutiny to prevent further cardiac strain.
Concurrently, the patient's renal function continues to pose a challenge. Despite adjustments to diuretic therapy aimed at optimizing fluid status, urine output remains critically low at 15 mL/hr, and serum creatinine has further increased to 2.5 mg/dL. These indicators of worsening acute kidney injury prompt the consideration of renal replacement therapy if the trend persists. The team also evaluates the patient's fluid status, carefully balancing the need to maintain adequate perfusion without exacerbating the cardiac workload or risk of pulmonary congestion.
The decision to proceed with percutaneous coronary intervention (PCI) becomes more pressing as the patient remains at risk for further ischemic events. The interdisciplinary team prepares for the procedure, ensuring all necessary precautions are taken to accommodate the patient's current hemodynamic and renal challenges. This coordinated approach underscores the critical need for meticulous planning and adaptive strategies as the patient's clinical trajectory continues to evolve. The team remains poised to address any new complications that may arise, with a focus on optimizing outcomes through timely and evidence-based interventions.
Section 5
As the team continues to monitor the patient's status, a new complication emerges. Approximately two hours after initiating NIPPV, the patient begins to exhibit signs of increased agitation and confusion. The nursing staff quickly assesses the situation, noting that the patient's heart rate has escalated to 118 beats per minute, and the blood pressure has dropped further to 88/56 mmHg, raising concerns about the potential for cardiogenic shock. Oxygen saturation remains around 92% on NIPPV, but the altered mental status suggests cerebral hypoperfusion may be occurring.
In response to these changes, the team conducts a thorough reassessment. Repeat arterial blood gases reveal a pH of 7.33, PaCO2 of 50 mmHg, and PaO2 of 60 mmHg, indicating a slight worsening of respiratory acidosis. The elevated carbon dioxide levels could be contributing to the patient's confusion. Meanwhile, an urgent echocardiogram is performed, which shows a reduced ejection fraction of 35%, confirming the suspicion of diminished cardiac output. The patient's renal function remains compromised, with urine output decreasing further to 10 mL/hr and serum creatinine rising to 2.7 mg/dL, heightening the risk of acute kidney injury.
The interdisciplinary team promptly reassesses their management strategy. The cardiology team, led by the interventional cardiologist, decides to expedite the PCI to restore coronary perfusion and improve cardiac output. The nephrology consult recommends cautious fluid management to optimize renal perfusion without exacerbating cardiac strain. The nursing team ensures vigilant monitoring of vital signs and neurological status, prepared to escalate care as necessary. This coordinated effort highlights the importance of adaptive clinical reasoning in response to evolving complications, aiming to stabilize the patient and prevent further deterioration.